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Introduction: With the COVID-19 pandemic, individuals have been forced to follow strict social isolation
guidelines. While crucial to control the pandemic, isolation might have a significant impact on produc-
tivity and mental health. Especially for researchers working in healthcare, the current situation is com-
plex. We therefore carried out a survey amongst researchers in the field of radiation oncology to gain
insights on the impact of social isolation and working from home and to guide future work.
Materials and methods: An online survey was conducted between March 27th and April 5th, 2020. The
first part contained 14 questions intended to capture an overview of the specific aspects related to
research while in isolation. The second (optional) part of the questionnaire was the validated Hospital
Anxiety and Depression Scale (HADS), a self-reported measure used to assess levels of anxiety and
depressive symptoms.
Results: From 543 survey participants, 48.8% reported to work full-time from home. The impact on per-
ceived productivity, with 71.2% of participants feeling less productive, caused 58% of participants to feel
some level of guilt.
Compared to normative data, relatively high levels of anxiety and depressive symptoms were recorded
for the 335 participants who filled out the HADS questionnaire. Group comparisons found the presence of
a supportive institutional program as the sole factor of statistical significance in both anxiety and depres-
sive symptom levels. People having to work full-time on location showed higher depressive symptom
levels than those working from home. Anxiety scores were negatively correlated with the number of
research years.
Conclusion: Results of the survey showed there is a non-negligible impact on both productivity and men-
tal health. As the radiation oncology research community was forced to work from home during the
COVID-19 pandemic, lessons can be learned to face future adverse situations but also to improve
work-life balance in general.
 2020 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and
Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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With the outbreak and spread of the Severe Acute Respiratory
Syndrome CoronaVirus 2 (SARS-CoV-2), the virus responsible for
Coronavirus disease 2019 (COVID-19), an unprecedented scenario
took hold of every aspect of our life.
The World Health Organisation (WHO) designated COVID-19 as
a public health emergency on January 30th, 2020 and as a pan-
demic on March 11th [1,2]. Two days earlier, on March 9th, the
Italian government declared the entire country in ‘lockdown’,
restricting its citizens to home-confinement and closing its borders
and airports to all non-essential travel [3]. Soon, other European
countries followed with a partial or full lockdown (Fig. 1). Most
countries, including those who refrained from lockdown, imposed
strict social distancing and isolation guidelines requiring people to
work from home whenever possible. Often, this was installed from
one day to another with citizens having to adapt in a matter of
hours.
In early March, the WHO emphasized the need to ‘‘stop, contain,
control, delay and reduce the impact of this virus at every opportu-
nity” [4]. While the control of the pandemic and the safety and
continuity of healthcare programs are primary concerns, it is also
important to minimize the indirect impact on people forced to
work from home. Isolation, while crucial to keep the spread of
SARS-CoV-2 under control, can have a significant impact on phys-
ical and mental health [5]. In a large systematic review, it was
found that across the general population, actual and perceived iso-
lation is as strongly associated with increased risk for early mortal-
ity as smoking [6].
As academia is already associated with high pressure and
expectations on productivity, the isolation measures might have
a non-negligible impact on researchers, who often rely on time-
limited funding or have to deliver scientific output under strict
deadlines [7]. Technological developments have facilitated remote
working for most researchers. However, having it imposed as the
main or sole mode of work at short notice may have a negative
impact on productivity and mental health, as the creativity of
research benefits from interactions between group members and
with collaborators in other institutes or in the industry. Research-
ers with university affiliations might have seen their teaching
workload increase as classes had to suddenly be transferred to
online formats. Laboratory researchers might have lost access to
their labs especially if these were located in COVID-hospitals [8].8-M
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Fig. 1. Cumulative number of European countries implementing COVID-19 related
measures over a time span between March 8th and 29th. Dates indicate the
moment measures were implemented. School closure is defined as a nationwide
closure of either (pre-)elementary school, high school or university. Lockdown is
defined as home-confinement, closing the borders or airports to all non-essential
travel. Survey results were gathered from the 29th of March to the 5th of April
2020.Gathering patient data, e.g. for clinical trials, became more difficult
if not impossible. Researchers with clinical training might have
become fully occupied with clinical duties or even be transferred
to other services to directly treat COVID-19 patients. This might
have also hindered research continuity for those remaining at
home, as interaction with colleagues still involved in patient care
has to be avoided. Especially for researchers working in healthcare,
the current situation is complex. While some studies found
traumatization to be higher in the public than in healthcare per-
sonnel involved in treating patients infected with COVID-19, other
studies report direct contact with COVID-19 as a predictive factor
for increased psychological distress [9–13].
Radiation oncology is a highly interdisciplinary field, with
researchers having various backgrounds such as radiobiology,
medical physics, computer science and/or clinical studies. There-
fore, it is difficult to predict the impact of the COVID-19 pandemic
and related measures on their mental health and we hypothesise
that the very different personal circumstances may result in differ-
ent effects and coping mechanisms. In particular, we hypothesized
that three groups experienced substantial negative impact of the
current pandemic on their mental health: a) researchers in train-
ing, such as PhD students with strict deadlines, b) those still
involved in clinical duties confronted with the crisis situation in
healthcare, and c) those completely isolated at home.
We therefore carried out a survey amongst researchers in the
field of radiation oncology, including a validated anxiety and
depressive symptoms test, with the aim to assess the impact of
social isolation and working from home on mental health and to
identify possible high-risk groups to guide future work in mitigat-
ing this impact.
2. Materials and methods
An online survey was disseminated amongst researchers in the
field of radiation oncology between March 27th and April 5th, 2020
(see supplementary material). Participants were invited via email
using the European SocieTy for Radiotherapy and Oncology
(ESTRO) membership database (3850 recipients), social media,
national radiation oncology societies and their young member
working groups and personal networks. The survey platform
restricted survey participation to one per device, limiting the
chance of multiple participations per person.
The questionnaire was anonymous and consisted of two parts.
The first part contained 14 questions intended to capture an over-
view of the specific aspects related to research while in isolation.
Aspects such as family duties, caring for oneself or loved ones
affected by the disease or other aspects that affect the general pop-
ulation in a similar manner were not specifically surveyed but par-
ticipants could include this in free-text responses. The second
(optional) part of the questionnaire was the Hospital Anxiety and
Depression Scale (HADS) [14,15]. The HADS is a self-reported
measure used to assess psychological distress in both clinical and
non-clinical populations. It includes 14 items representing two
subscales: anxiety (HADS-A) and depression (HADS-D). Each sub-
scale consists of 7 items rated on a 0–3 scale, with the total score
ranging from 0 to 21. For both scales, a score of 8 or more suggests
a clinically significant level of depressive/anxiety symptoms. The
HADS has shown good concurrent validity, test–retest reliability,
and internal consistency (Cronbach’s alphas ranging from 0.82 to
0.90) [16].
Statistical analyses of the survey results were carried out with
the Statistical Package for Social Science, version 26.0 (IBM SPSS
Statistics for Windows, Armonk, NY, USA). Indices of asymmetry
and kurtosis were used to test for normality of the data. Values
for asymmetry and kurtosis between –1 and + 1 were considered
acceptable to prove normal univariate distribution. Comparisons
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were performed by means of a t-tests or one-way Analysis of Vari-
ance (ANOVA), as appropriate. The effect size was determined by
calculating Cohen’s d or partial eta-squared (g2). Spearman’s
rank-order correlations were run to evaluate the possible relation-
ships between ordinal variables extracted from the first part of the
survey and the HADS scores.
Additional comparisons were performed to investigate the pos-
sible presence of group differences, considering only those partic-
ipants who scored above the clinical significance cut-off point
(8). A p-value < 0.05 was considered statistically significant.Fig. 3. Percentage of participants who take certain measures to cope with isolation
(Q13) overall and grouped by effect (Q14). (33 participants did not grade the effect
of the measures).3. Results
From the survey, 543 participants were identified as researchers
working in the field of radiation oncology with varying levels of
experience, field of research and additional duties besides research
(Table A1). At the time of answering the survey, participants were
working in 45 different countries of which the large majority
(85.7%) was located in Europe (Table A2). Most of the participants
worked from home full-time (48.8%) or part-time (26.5%) while
24.7% worked full-time on location (hospital, laboratory or office).
Many participants made use of digital communication to stay in
contact with either family and friends (76.3%) or colleagues
(68.4%), while 4% of participants replied to have little or no contact
with anyone.
The survey showed that the outbreak of COVID-19 had an
impact on perceived productivity, with 71.2% of participants feel-
ing either a lot or a little less productive than pre-pandemic, while
11.2% responded that they felt a little or a lot more productive. The
feeling of guilt associated with the participants’ perceived change
in productivity is illustrated in Fig. 2, with a little or a lot of guilt
being more abundant when productivity declined.
Participants were asked which measures they took to cope with
isolation and if these measures helped. Exercise at home and
online social interactions with friends/family or with colleagues
were the most popular answers, especially among participants
who said the measures helped a lot (Fig. 3). Other measures
entered by participants in a free-text field included creative and
artistic hobbies, reading, films, video games, music and cooking
(5.3% of all the participants) or spending time with family (4.4%).
Although not explicitly asked, five participants (1%) wrote that
they had more time with family in the current situation. Outdoor
activities, meditation, yoga, relaxation and self-care as well as
housework/gardening were also entered by participants. Only 5%
of the participants said these measures did not help.
Despite the measures, over half of the participants (67%)
declared that they felt isolation had a negative impact on theirFig. 2. Level of perceived productivity (Q8) compared to pre-COVID-19 outbreamental health while 5% said it had a positive one. Further, 21% of
participants were worried it would become an issue soon or very
soon while only 32% said they thought they could continue in iso-
lation for a few more months or longer (Fig. 4A). A majority of par-
ticipants said they could talk to friends and family to cope with
mental health issues. Institutional programs existed or were
recently created for 19% and 11% of participants respectively. How-
ever, 15% of the participants said there was no form of mental
health support available to them within their institutes (Fig. 4B).
Of the 543 participants, 335 (61.7%) completed the HADS ques-
tionnaire (part 2) of the survey. All variables included in the anal-
yses were normally distributed according to the criteria mentioned
earlier (kurtosis values ranging from 0.829 to + 0.508; asymme-
try values ranging from + 0.128 to + 0.957). The Cronbach’s alpha
values in our sample were a = 0.84 (HADS-A) and a = 0.78
(HADS-D). A detailed overview of the statistical analysis results
can be found in Appendix A.k, together with the participants’ feeling of guilt around productivity (Q9).
Fig. 4. Self-assessed impact of isolation on mental health (top) and available means to cope with mental health problems (bottom).
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reported a clinically relevant level of anxiety symptoms (HADS-
A  8) and depressive symptoms (HADS-D  8), respectively
(Fig. 5). Overall, participants reported higher levels of anxiety
symptoms than depressive symptoms (HADS-A vs. HADS-D,
mean ± SD: 7.02 ± 3.90 vs. 5.02 ± 3.46, p < .001).
Group comparisons on both HADS-A and HADS-D scores to
identify possible high-risk groups or causes for increased anxiety
and/or depressive symptoms are summarized in Table 1. As
ANOVA showed no significant difference between part-time and
full-time work from home, the two groups work at home (part-
or full-time) and work on location (full-time) were compared using
t-test. Regarding group comparisons on both the levels of anxiety
and depressive symptoms, a univariate ANOVA showed the pres-
ence of significant differences between participants who had sup-
port from institution programs vs. participants who had support
from colleagues/family/friends vs. participants who had no supportat all (HADS-A: mean ± SD: 6.30 ± 3.85 vs. 7.12 ± 3.82 vs.
7.81 ± 4.03; p = .038, HADS-D: mean ± SD: 4.29 ± 3.02 vs. 4.80 ±
3. 32 vs. 6.56 ± 4.06; p < .001). Particularly, post-hoc tests revealed
a statistically significant difference between people who received
support from institution programs and people who had no support.
Regarding group differences on depressive symptom scores only,
results of t-tests showed the presence of significant differences
between participants who have virtual or non-virtual contacts
with colleagues/friends/family vs. no contact at all (mean ± SD:
4.97 ± 3.42 vs. 7.57 ± 4.39; p = .049), and between participants
who work on location vs. from home (mean ± SD: 5.94 ± 4.23 vs.
4.75 ± 3.14; p = .024). For all other group comparisons, no signifi-
cant differences were detected on either the HADS-A or HADS-D
scores (Appendix A).
Based on Spearman’s rank-order correlation analysis, results
showed the presence of significant and negative associations
between anxiety symptoms and years of research experience
Fig. 5. Distribution of HADS-A and HADS-D scores of all 335 participants. Scores for participants with a clinically significant level of depression/anxiety symptoms (HADS
score  8) are in the black box.
Table 1
Group comparisons for HADS-A and HADS-D.
Number (%) HADS-Amean ± SD p HADS-Dmean ± SD p
PhD students 79 (23.6) 7.32 ± 4.51 0.490 5.04 ± 3.80 0.967
Other professionals 256 (76.4) 6.93 ± 3.70 5.02 ± 3.35
In training* 119 (35.5) 7.47 ± 4.25 0.134 5.31 ± 3.97 0.292
Not in training 216 (64.5) 6.77 ± 3.68 4.87 ± 3.14
Clinical duties 162 (48.4) 6.88 ± 3.61 0.513 5.24 ± 3.63 0.267
No clinical duties 173 (51.6) 7.16 ± 4.16 4.82 ± 3.28
Work at homey 257 (76.7) 7.50 ± 4.15 0.216 4.75 ± 3.14 0.024
Work at office 78 (23.3) 6.88 ± 3.82 5.94 ± 4.23
Support
from institution 101 (30.1) 6.30 ± 3.85 0.038 4.29 ± 3.02 <0.001
from family/friends only 162 (48.4) 7.12 ± 3.82 4.80 ± 3. 32
no support 72 (21.5) 7.81 ± 4.03 6.56 ± 4.06
Virtual / non-virtual contact 328 (97.9) 7.02 ± 3.92 0.934 4.97 ± 3.42 0.049
No contact 7 (2.1) 7.14 ± 2.97 7.57 ± 4.39
Coping measures 311 (92.8) 7.06 ± 3.90 0.498 5.00 ± 3.34 0.707
No coping measures 24 (7.2) 6.50 ± 3.96 5.38 ± 4.79
*MSc students + PhD students + MD residents + MD or Medical Physicist in training. yfull-time + part-time at home. Results in bold indicate a statistically significant
difference.
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symptoms and the perceived productivity levels after COVID-19
outbreak (HADS-A: rs(333) = -0.112, p = .40; HADS-D:
rs(333) = -0.235, p < .001). Significant positive correlations were
found, instead, between anxiety/depressive symptoms and the
feeling of guilt about current productivity levels (HADS-A:
rs(333) = 0.312, p < .001; HADS-D: rs(333) = 0.334, p < .001), the
negativity of the self-perceived impact of isolation on mental
health (HADS-A: rs(333) = 0.384, p < .001; HADS-D: rs(333)
= 0.411, p < .001) and the worry about mental health in case of pro-
longed isolation (HADS-A: rs(333) = 0.402, p < .001; HADS-D:
rs(333) = 0.441, p < .001).
Next, we considered only participants who presented with a
clinically significant level of anxiety or depressive symptoms
(HADS-A/D  8). Regarding anxiety symptoms, results of t-tests
showed the presence of significant differences on the HADS-A
scores between PhD students (n = 35) vs. other professionals
(n = 103) (mean ± SD: 11.57 ± 2.79 vs. 10.53 ± 2.56; p = .045). As
far as depressive symptoms are concerned, results of t-tests
showed the presence of significant differences on the HADS-D
scores between participants who are in training (n = 31) vs. not
in training (n = 40) (mean ± SD: 11.03 ± 2.36 vs. 9.93 ± 1.81;
p = .029), and between participants who have virtual or non-
virtual contacts with colleagues/friends/family (n = 69) vs. no con-
tact at all (n = 2) (mean ± SD: 10.32 ± 2.08 vs. 13.50 ± 2.12;p = .036). For all other group comparisons, no significant differ-
ences were detected on either the HADS-A or HADS-D scores (p-
values > 0.05).4. Discussion
A survey among researchers in the field of radiation oncology
was carried out during one of the early weeks of the COVID-19
pandemic, when isolation measures had been installed for a max-
imum of 3 weeks, depending on the country. At the time of data
collection, the total duration of the lockdown measures was
unknown in most countries but expected to last for several
months. The survey gathered a total of 543, of which 335 filled-
in the included HADS questionnaire. The aim was to gain insight
into the impact of the current COVID-19 pandemic and isolation
measures on productivity and mental health in this population.
We hypothesized that three groups may experience substantial
negative impact of the current pandemic on their mental health:
a) researchers in training, such as PhD students with strict deadli-
nes, b) those still involved in clinical duties confronted with the
crisis situation in healthcare, and c) those completely isolated at
home.
Several European studies have gathered normative HADS data
which can be used as a benchmark. Mean normative anxiety scores
58 J. Dhont et al. / Clinical and Translational Radiation Oncology 24 (2020) 53–59range from 3.9 to 6.4, with most studies reporting higher anxiety in
women. Mean normative depressive symptom scores are more
homogeneous, ranging between 3.0 and 3.7, with a maximum of
4.0 reported by a Swedish study and several studies reporting a
positive trend between depressive symptoms and age [17–19].
Compared to these normative data, relatively high levels of anxiety
and depressive symptoms were recorded in the present study, with
mean ± SD scores over all participants of 7.02 ± 3.90 for anxiety
and 5.02 ± 3.46 for depressive symptoms. Furthermore, a signifi-
cant number of individuals reported a clinically relevant level of
anxiety (41%) and of depressive (21%) symptoms. A limitation is
that participants were not asked about gender or age and so strat-
ification based on these factors was not possible. Another limita-
tion is the lack of assessment of pre-existing mental or somatic
health issues in the studied population prior to the COVID-19 pan-
demic and no baseline levels for the pre-pandemic period were
recoded for similar populations. Therefore, the higher levels of anx-
iety and depressive symptoms in our sample may be due to several
factors other than the pandemic. Nevertheless, the majority of par-
ticipants (67%) reported feeling a negative impact of isolation on
their mental health, which was correlated with the HADS scores;
while 22% indicated to be a little or very worried about their men-
tal health in case of prolonged isolation. This points to the interpre-
tation that the pandemic had an effect on the level of anxiety and
depression in our population.
Our results also indicate that the current unprecedented cir-
cumstances have a significant impact on perceived productivity,
with most participants (71.1%) feeling less productive. Moreover,
this change in perceived productivity causes more than half the
participants (58%) to feel some level of guilt. Both these indirect
consequences of the current pandemic were found to be associated
with the participants’ levels of anxiety (HADS-A) and depressive
symptoms (HADS-D). Based on these findings, (academic) institu-
tions are encouraged to acknowledge human limitations in a time
of crisis and support the mental health of their researchers. The
presence of a supportive institutional program was found to be
the sole factor of statistical significance in both anxiety and depres-
sive symptom levels, and so creating such a program and/or
reminding researchers of its existence may help reduce the risk
of anxiety and depressive disorders among researchers. Early inter-
vention measures should be taken to alleviate the psychological
issues and avoid long-term consequences such as burn-out [20].
Generally speaking, whenever trying to specifically address the
potential sources of anxiety and fear, it is more important and
valuable to focus on addressing the specific concerns, rather than
teaching generic approaches to manage stress reduction or
enhance resilience [13]. It is considered useful to investigate what
people are concerned about, what type of message and indication
they feel they need from their leaders, and which could be other
tangible sources of support of which they believe they could
mostly take advantage. As the field of radiation oncology is highly
interdisciplinary, concerns and helpful support are likely to be
quite diverse and require further investigation.
Significantly higher depressive symptom levels were observed
in participants who are still required to work full-time on location
compared to those working full- or part-time from home, indicat-
ing that isolation is likely not the main contributor to increased
depressive symptom levels. With a mean HADS-D score of
5.94 ± 4.23, participants required to work full-time on location
are well above reported normative values for depressive symptoms
(range: 3–4). Several factors could serve as an explanation such as
fear of contamination, fear of contaminating family members or a
high exposure to critically ill patients, though clinical duties were
no indicator for increased anxiety nor depressive symptoms. The
exact ratio of time spent working at home vs. on location was
not requested. This encourages additional investigation in the rela-tionship between the ratio of time spent working at home vs on
location and HADS scores. It is important to observe that one of
the mechanisms by which isolation may have an impact on the
psychological aspects of an individual is through the role of loneli-
ness as a mediator. This has been demonstrated, for example, in
older adults, where the effect of social isolation on cognitive func-
tion decline was found to be influenced by the indirect effect of
loneliness [21]. This means that, even if constrained within a con-
text of isolation, if a person can maintain social relations and cope
with feelings of loneliness, this can potentially mitigate the impact
on mental health. In this sense, technology can be very helpful to
help researchers feel connected despite isolation [22].
Despite the generally negative impact of isolation on mental
health, 5% of respondents said that isolation had a positive impact
on their mental health. Notably, some participants noted having
more time to spend with their family or for self-care. More time
at home instead of commuting and the additional flexibility may
positively balance the effects of isolation [23]. Working from home
is also likely beneficial for people having a toxic professional envi-
ronment [24]. Just over 20% of the respondents to the Nature PhD
survey reported experiencing harassment and discrimination at
the workplace [8]. In circumstances other than a global pandemic,
allowing more flexibility and remote working may help bridge the
gender gap, especially for early-career researcher [25].
Several group comparisons on both HADS-A and HADS-D scores
were performed in this study to identify possible high-risk groups
based on our hypothesis. Obtaining a PhD or a higher education
degree is a once-in-a-lifetime experience and achievement and
although it can be a very rewarding experience, PhD students
experience particularly high levels of psychological distress,
including depressive and anxiety symptoms. In fact, over a third
of the participants to the Nature 2019 PhD survey have sought help
for depression and anxiety, and only 26% of them were satisfied
with the help received from their institutions [8]. In our study,
the overall levels of anxiety and depressive symptoms were not
statistically different for PhD students and non-PhD students or
in-training members vs non-in-training members. However, the
years of research experience was found to be correlated with anx-
iety and when considering only participants with a clinically sig-
nificant level of anxiety or depressive symptoms, indications
were found that the severity of the symptoms was higher in PhD
students (anxiety score) or in-training participants (depression
score) compared to non-PhD students or non-in-training partici-
pants, respectively. Given the small number of participants in this
sub-analysis compared to the overall prevalence analysis, these
results should be interpreted with caution and confirmed in a lar-
ger cohort.
The work conducted in this study was an initial impact assess-
ment of the current pandemic and isolation regulations on the pro-
ductivity and mental health of researchers working in radiation
oncology. 543 invitees responded to the survey in the relatively
short timeframe of one week, representing a snapshot of a very
dynamic situation that followed different time courses per country.
The number of respondents (543) can be compared to the ESTRO
membership database (3850 members), however, other channels
were used to promote the survey as well. The survey was only
addressed to individuals involved in research. Other possible rea-
sons for not responding include not having the time to respond
possibly due to COVID-19 related circumstances, or not seeing its
relevance. This could have created a nonresponse bias in the
reported results in this manuscript which should be considered
when interpreting the results. However, we believe that our sam-
ple nonetheless provides important insights into how the radiation
oncology research community was affected by the pandemic. A
focus group will further investigate the possible underlying causes
or consequences of the present results and what constitutes
J. Dhont et al. / Clinical and Translational Radiation Oncology 24 (2020) 53–59 59helpful support from institutions. We believe that both this survey
and further analysis are relevant for a number of future scenario’s,
including global (epidemic) situations but also those which may
occur on a smaller or even a personal level such as medium to
long-term caring duties or illness, where a researcher or group of
researchers has to work from home.
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